ArticleGenome medicine2021

Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naïve study.

Jason K Sicklick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.